These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 25592646)

  • 1. Intra-tumoural vessel area estimated by expression of epidermal growth factor-like domain 7 and microRNA-126 in primary tumours and metastases of patients with colorectal cancer: a descriptive study.
    Hansen TF; Nielsen BS; Jakobsen A; Sørensen FB
    J Transl Med; 2015 Jan; 13():10. PubMed ID: 25592646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal growth factor-like domain 7 predicts response to first-line chemotherapy and bevacizumab in patients with metastatic colorectal cancer.
    Hansen TF; Nielsen BS; Sørensen FB; Johnsson A; Jakobsen A
    Mol Cancer Ther; 2014 Sep; 13(9):2238-45. PubMed ID: 25140000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HER3 expression in patients with primary colorectal cancer and corresponding lymph node metastases related to clinical outcome.
    Lédel F; Hallström M; Ragnhammar P; Öhrling K; Edler D
    Eur J Cancer; 2014 Feb; 50(3):656-62. PubMed ID: 24300455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HER3 expression in primary colorectal cancer including corresponding metastases in lymph node and liver.
    Lédel F; Stenstedt K; Hallström M; Ragnhammar P; Edler D
    Acta Oncol; 2015 Apr; 54(4):480-6. PubMed ID: 25601452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of p16 in lymph node metastases of adjuvantly treated stage III colorectal cancer patients identifies poor prognostic subgroups: a retrospective analysis of biomarkers in matched primary tumor and lymph node metastases.
    Karamitopoulou E; Zlobec I; Koumarianou A; Patsouris ES; Peros G; Lugli A
    Cancer; 2010 Oct; 116(19):4474-86. PubMed ID: 20572035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancer.
    Lu Y; Jingyan G; Baorong S; Peng J; Xu Y; Cai S
    Cancer Biomark; 2012; 11(5):219-26. PubMed ID: 23220854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarker expression and St Gallen molecular subtype classification in primary tumours, synchronous lymph node metastases and asynchronous relapses in primary breast cancer patients with 10 years' follow-up.
    Falck AK; Bendahl PO; Chebil G; Olsson H; Fernö M; Rydén L
    Breast Cancer Res Treat; 2013 Jul; 140(1):93-104. PubMed ID: 23807420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiogenesis and hypoxia in lymph node metastases is predicted by the angiogenesis and hypoxia in the primary tumour in patients with breast cancer.
    Van den Eynden GG; Van der Auwera I; Van Laere SJ; Colpaert CG; Turley H; Harris AL; van Dam P; Dirix LY; Vermeulen PB; Van Marck EA
    Br J Cancer; 2005 Nov; 93(10):1128-36. PubMed ID: 16251878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High epidermal growth factor receptor expression in metastatic colorectal cancer lymph nodes may be more prognostic of poor survival than in primary tumor.
    Deng Y; Kurland BF; Wang J; Bi J; Li W; Rao S; Lan P; Lin T; Lin E
    Am J Clin Oncol; 2009 Jun; 32(3):245-52. PubMed ID: 19451802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in AgNOR quantity between colorectal cancer and corresponding metastases: are they useful for prognostic purposes?
    Giuffrè G; Barresi G; Speciale G; Sarnelli R; Gioffrè Florio MA; Tuccari G
    Eur J Histochem; 1997; 41(2):111-8. PubMed ID: 9271703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of neuroendocrine differentiation and KRAS/NRAS/BRAF/PIK3CA/TP53 mutation status in primary and metastatic colorectal cancer.
    Kleist B; Kempa M; Novy M; Oberkanins C; Xu L; Li G; Loland C; Poetsch M
    Int J Clin Exp Pathol; 2014; 7(9):5927-39. PubMed ID: 25337237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression of CYP2W1 in colorectal primary tumors, corresponding lymph node metastases and liver metastases.
    Stenstedt K; Hallstrom M; Lédel F; Ragnhammar P; Ingelman-Sundberg M; Johansson I; Edler D
    Acta Oncol; 2014 Jul; 53(7):885-91. PubMed ID: 24625228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Her2 amplification is significantly more frequent in lymph node metastases from urothelial bladder cancer than in the primary tumours.
    Fleischmann A; Rotzer D; Seiler R; Studer UE; Thalmann GN
    Eur Urol; 2011 Aug; 60(2):350-7. PubMed ID: 21640482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The miRNA-200 family and miRNA-9 exhibit differential expression in primary versus corresponding metastatic tissue in breast cancer.
    Gravgaard KH; Lyng MB; Laenkholm AV; Søkilde R; Nielsen BS; Litman T; Ditzel HJ
    Breast Cancer Res Treat; 2012 Jul; 134(1):207-17. PubMed ID: 22294488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis.
    Hu WG; Li JW; Feng B; Beveridge M; Yue F; Lu AG; Ma JJ; Wang ML; Guo Y; Jin XL; Zheng MH
    Eur Surg Res; 2007; 39(4):229-38. PubMed ID: 17446709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of microRNA-214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expression.
    Chen DL; Wang ZQ; Zeng ZL; Wu WJ; Zhang DS; Luo HY; Wang F; Qiu MZ; Wang DS; Ren C; Wang FH; Chiao LJ; Pelicano H; Huang P; Li YH; Xu RH
    Hepatology; 2014 Aug; 60(2):598-609. PubMed ID: 24616020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ErbB 1-4 expression alterations in primary colorectal cancers and their corresponding metastases.
    Ljuslinder I; Malmer B; Isaksson-Mettävainio M; Oberg A; Henriksson R; Stenling R; Palmqvist R
    Anticancer Res; 2009 May; 29(5):1489-94. PubMed ID: 19443355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nodal metastasis microRNA expression correlates with the primary tumour in MTC.
    Gundara JS; Zhao JT; Gill AJ; Clifton-Bligh R; Robinson BG; Delbridge L; Sidhu SB
    ANZ J Surg; 2014 Apr; 84(4):235-9. PubMed ID: 23072640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MMP7 expression in colorectal tumours of different stages.
    Polistena A; Cucina A; Dinicola S; Stene C; Cavallaro G; Ciardi A; Orlando G; Arena R; D'Ermo G; Cavallaro A; Johnson LB; De Toma G
    In Vivo; 2014; 28(1):105-10. PubMed ID: 24425843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.